-
Effectiveness and Safety of Radiofrequency Nucleolysis for Chronic or Acute Low Back Pain
Sep 9, 2025, 16:22 PM -
Evaluating the Impact of International Drug Pricing Strategies on Indian State-Level
Sep 9, 2025, 16:22 PM -
Metamodels SHAP Analysis: Unearthing Data Interactions
Sep 9, 2025, 16:22 PM -
To What Endpoint? Exploring Clinical Outcome Assessments of Pain in Phase 2 and 3 Trials and Drug Labels in Women’s Health Conditions
Sep 9, 2025, 16:22 PM -
Extending Survival in Glioblastoma: Real-World Evidence of Post-Progression Benefit From Tumor-Treating Fields Therapy
Sep 9, 2025, 16:22 PM -
Digital Twins: Hype or Hope for Better Health Outcomes
Sep 9, 2025, 16:22 PM -
Changes in the Epidemiological Indicators of Female Infertility in Europe 1991-2021
Sep 9, 2025, 16:22 PM -
The Natural History of Pancreatic Cancer and the Effectiveness of Screening a Model-Based Analysis
Sep 9, 2025, 16:22 PM -
Artificial Intelligence-Based Population, Intervention, Comparator, and Outcome (PICO) Prediction for European Union (EU) Joint Clinical Assessment (JCA)
Sep 9, 2025, 16:22 PM -
Impact of Nonclinically Driven Inhaler Initiation or Switch on Carbon (CO2) Emissions and Healthcare Costs for COPD Patients Using Single-Inhaler Triple Therapy (SITT)
Sep 9, 2025, 16:22 PM -
Unlocking Value Early: Insights Into NICE’s Early Value Assessments and Evidence-Generation Plans for Medical Technologies
Sep 9, 2025, 16:22 PM -
Evaluating the Cost-Effectiveness of High-Dose Influenza Vaccination for Adults Aged 60 Years and Older in Austria
Sep 9, 2025, 16:22 PM -
Assessing Known Groups and Convergent Validity of the EQ-5D-5L in Assessing the Health-Related Quality of Life of Individuals With Obesity Who Have and Have Not Received Bariatric Surgery
Sep 9, 2025, 16:22 PM -
Treatments for Children With Newly Diagnosed Medulloblastoma: A Systematic Review Of Randomized Controlled Trials
Sep 9, 2025, 16:22 PM -
Navigating HTA and Innovation: Oncologists’ Perspectives on Access to Cancer Therapies in Bulgaria
Sep 9, 2025, 16:22 PM -
Using Expert Consensus to Expand Access in Rare Disease Populations: Generating Evidence for Patients With Permanently Ventilated Spinal Muscular Atrophy
Sep 9, 2025, 16:22 PM -
A New Regulatory-Grade Chronic Disease Cohort Simulator: Leveraging the Large, Deep, and Long Constances Cohort Linked and Matched to the SNDS in France
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Sparsentan for the Treatment of Immunoglobulin A Nephropathy in Spain
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Introducing the Elecsys® PRO-C3 Assay as Part of the ADAPT Algorithm for Assessing the Severity of Hepatic Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the UK
Sep 9, 2025, 16:22 PM -
Systematic Review of Decision-Analytic Models Estimating the Economic Impact of Prescription Opioid Use and Associated Adverse Events
Sep 9, 2025, 16:22 PM
